PETROS.png
Petros Pharmaceuticals Responds to Fraudulent Press Release
28 juil. 2022 10h27 HE | Petros Pharmaceuticals, Inc.
NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today confirmed that a press release issued on July 28,...
Dr. Drew Pinsky
Petros Pharmaceuticals Kicks Off Social Media Campaign with Celebrity Physician Dr. Drew Pinsky
19 juil. 2022 09h15 HE | Petros Pharmaceuticals, Inc.
NEW YORK, July 19, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announces that it has signed a compensated...
PETROS.png
Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
16 mai 2022 17h00 HE | Petros Pharmaceuticals, Inc.
NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today announced financial...
PETROS.png
Petros Pharmaceuticals to Pursue 505(B)(2) Pathway for H-100, Company’s Novel Topical Investigational Treatment for Peyronie’s Disease Which Impacts More Than 1 in 10 Men in the US
03 mai 2022 09h23 HE | Petros Pharmaceuticals, Inc.
NEW YORK, May 03, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today they will be pursuing the 505(b)(2)...
PETROS.png
Petros Pharmaceuticals to Present at the Planet MicroCap Showcase 2022
27 avr. 2022 21h25 HE | Petros Pharmaceuticals, Inc.
NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President and Chief Commercial...
PETROS.png
Petros Pharmaceuticals, Inc. Engages Massachusetts General Hospital in a Sponsored Research Agreement for Tissue-Specific Oxygenation Sensor Technology
26 avr. 2022 09h15 HE | Petros Pharmaceuticals, Inc.
NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Petros, Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today announces it has entered into a Sponsored...
Petros Pharmaceuticals Announces Positive Results of Over-the-Counter (OTC) Label Comprehension Study for Erectile Dysfunction Drug STENDRA (avanafil)
19 avr. 2022 09h15 HE | Petros Pharmaceuticals, Inc.
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today provides positive...
Petros Pharmaceuticals to Present at the Q1 Investor Summit Conference
03 mars 2022 08h00 HE | Petros Pharmaceuticals, Inc.
NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President and Chief Commercial...
Petros Pharmaceuticals to Participate in NobleCon17
19 janv. 2021 08h00 HE | Petros Pharmaceuticals, Inc.
NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals (Nasdaq: PTPI) today announces that its president and chief commercial officer Fady Boctor will present at NobleCon17 - Noble...